- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 5/40 - Mineralocorticosteroids, e.g. aldosteroneDrugs increasing or potentiating the activity of mineralocorticosteroids
Patent holdings for IPC class A61P 5/40
Total number of patents in this class: 40
10-year publication summary
|
3
|
0
|
3
|
2
|
0
|
3
|
1
|
3
|
4
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ardelyx, Inc. | 115 |
4 |
| F. Hoffmann-La Roche AG | 7828 |
3 |
| Hoffmann-La Roche Inc. | 3679 |
3 |
| Arrowhead Pharmaceuticals, Inc. | 336 |
2 |
| Eli Lilly and Company | 4036 |
2 |
| Ono Pharmaceutical Co., Ltd. | 421 |
2 |
| Genesis Pharma SA | 7 |
2 |
| Glaxo Group Limited | 4315 |
1 |
| Bayer Schering Pharma AG | 348 |
1 |
| Bayer Pharma AG | 1028 |
1 |
| Takeda Pharmaceutical Company Limited | 2719 |
1 |
| Angion Biomedica Corp. | 59 |
1 |
| Apeptico Forschung und Entwicklung GmbH | 35 |
1 |
| Arana Therapeutics (Vic) Pty Ltd | 2 |
1 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 740 |
1 |
| Dainippon Sumitomo Pharma Co., Ltd. | 174 |
1 |
| Ivashchenko, Andrey Alexandrovich | 14 |
1 |
| KBP Biosciences Co., Ltd. | 29 |
1 |
| Medshine Discovery Inc. | 592 |
1 |
| Mitsubishi Tanabe Pharma Corporation | 465 |
1 |
| Other owners | 9 |